NSC689857 |
| Catalog No.GC69596 |
NSC689857는 유효한 EGFR 및 SCFSKP2 억제제로, Skp2-Cks1의 IC50는 36 μM입니다. NSC689857은 p27 인산화를 억제할 수 있으며 (IC50=30 μM), 다양한 종류의 암에서 서로 다른 활성을 나타냅니다. 특히 백혈병 세포주에 대한 내성 활성이 다른 암세포보다 높습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 241127-79-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for NSC689857
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for NSC689857
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *